Works matching IS 20406223 AND DT 2024


Results: 37
    1
    2
    3
    4
    5
    6
    7
    8
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis.

    Published in:
    Therapeutic Advances in Chronic Disease, 2024, p. 1, doi. 10.1177/20406223241247643
    By:
    • M. Boot, Annemieke;
    • Ariceta, Gema;
    • Beck-Nielsen, Signe Sparre;
    • Brandi, Maria Luisa;
    • Briot, Karine;
    • Collantes, Carmen de Lucas;
    • Giannini, Sandro;
    • Haffner, Dieter;
    • Keen, Richard;
    • Levtchenko, Elena;
    • Mughal, M. Zulf;
    • Makitie, Outi;
    • Nilsson, Ola;
    • Schnabel, Dirk;
    • Tripto-Shkolnik, Liana;
    • Zillikens, M. Carola;
    • Liu, Jonathan;
    • Tudor, Alina;
    • Emma, Francesco
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Tafamidis improves myocardial longitudinal strain in A97S transthyretin cardiac amyloidosis.

    Published in:
    Therapeutic Advances in Chronic Disease, 2024, p. 1, doi. 10.1177/20406223231222828
    By:
    • Wu, Yuan-Kun;
    • Yu, An-Li;
    • Cheng, Mei-Fang;
    • Lin, Lung-Chun;
    • Lee, Ming-Jen;
    • Chou, Chia-Hung;
    • Shun, Chia-Tung;
    • Hsueh, Hsueh-Wen;
    • Juang, Jimmy Jyh-Ming;
    • Tseng, Ping-Huei;
    • Lin, Siao-Ping;
    • Su, Mao-Yuan;
    • Chao, Chi-Chao;
    • Hsieh, Sung-Tsang;
    • Tsai, Cheng-Hsuan;
    • Lin, Yen-Hung
    Publication type:
    Article
    37